Annie Gong1, Samantha Leitold1, Julia Uhanova1, Gerald Y Minuk1,2. 1. Section of Hepatology, Department of Medicine, Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada. 2. Department of Pharmacology and Therapeutics, Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Abstract
INTRODUCTION AND AIM: Low serum ceruloplasmin levels can occur in patients without Wilson's disease (WD) liver disorders. When present, extensive, costly, and potentially harmful additional investigations for WD may be undertaken. The purpose of this study was to document the prevalence of low serum ceruloplasmin levels in adult patients without WD and describe the features commonly associated with this finding. MATERIALS AND METHODS: Serum ceruloplasmin levels were measured by an enzymatic assay in 3040 adult patients attending an urban, liver diseases outpatient clinic. RESULTS: A total of 122 (4.0%) patients without WD had serum ceruloplasmin levels less than the lower limit of normal documented at their initial visit. Their mean age was 44 ± 14 years, and 80 (66%) were men. The Model for End-stage Liver Disease (MELD) score was 9.0 ± 4.0. Approximately, one half (65/122, 53%) had underlying viral hepatitis (52% hepatitis B and 48% hepatitis C). When compared with 64 MELD-matched control patients with normal or elevated serum ceruloplasmin levels, there were no significant differences in liver enzyme/function tests, ferritin, creatinine values, or survival. However, the low serum ceruloplasmin cohort patients were younger (43 ± 14 versus 52 ± 13 years, p = 0.0002), less often men (66% vs. 88%, p = 0.001), and viral hepatitis was significantly more common (53% versus 27%, p = 0.0005). CONCLUSION: Low serum ceruloplasmin levels were documented in 4.0% of adult patients without WD attending this urban liver diseases outpatient clinic. These patients tend to be younger, less often men, and more often have viral hepatitis as the underlying cause of their liver disease.
INTRODUCTION AND AIM: Low serum ceruloplasmin levels can occur in patients without Wilson's disease (WD) liver disorders. When present, extensive, costly, and potentially harmful additional investigations for WD may be undertaken. The purpose of this study was to document the prevalence of low serum ceruloplasmin levels in adult patients without WD and describe the features commonly associated with this finding. MATERIALS AND METHODS: Serum ceruloplasmin levels were measured by an enzymatic assay in 3040 adult patients attending an urban, liver diseases outpatient clinic. RESULTS: A total of 122 (4.0%) patients without WD had serum ceruloplasmin levels less than the lower limit of normal documented at their initial visit. Their mean age was 44 ± 14 years, and 80 (66%) were men. The Model for End-stage Liver Disease (MELD) score was 9.0 ± 4.0. Approximately, one half (65/122, 53%) had underlying viral hepatitis (52% hepatitis B and 48% hepatitis C). When compared with 64 MELD-matched control patients with normal or elevated serum ceruloplasmin levels, there were no significant differences in liver enzyme/function tests, ferritin, creatinine values, or survival. However, the low serum ceruloplasmin cohort patients were younger (43 ± 14 versus 52 ± 13 years, p = 0.0002), less often men (66% vs. 88%, p = 0.001), and viral hepatitis was significantly more common (53% versus 27%, p = 0.0005). CONCLUSION: Low serum ceruloplasmin levels were documented in 4.0% of adult patients without WD attending this urban liver diseases outpatient clinic. These patients tend to be younger, less often men, and more often have viral hepatitis as the underlying cause of their liver disease.
Authors: M J Czaja; F R Weiner; S J Schwarzenberg; I Sternlieb; I H Scheinberg; D H Van Thiel; N F LaRusso; M A Giambrone; R Kirschner; M L Koschinsky Journal: J Clin Invest Date: 1987-10 Impact factor: 14.808
Authors: Z Marecek; M Vulterinová; I Skála; J Pechar; P Doberský; O Schück; H Nádvorníková; I Heyrovský Journal: Clin Nephrol Date: 1978-01 Impact factor: 0.975
Authors: Christopher J Collins; Fan Yi; Remwilyn Dayuha; Phi Duong; Simon Horslen; Michelle Camarata; Ayse K Coskun; Roderick H J Houwen; Tudor L Pop; Heinz Zoller; Han-Wook Yoo; Sung Won Jung; Karl H Weiss; Michael L Schilsky; Peter Ferenci; Si Houn Hahn Journal: Gastroenterology Date: 2021-02-25 Impact factor: 22.682